APP and Alzheimer disease: Finally, the changes in the nanoscale organization of receptors and channels suggest the existence of major molecular rearrangements in APP/PS1 mice, remodelling GABAB–GIRK2 interactions, thus urging the design of corrective strategies towards rescuing GABAergic neurotransmission in AD.